In 2008, the New Zealand Government passed an amendment to reschedule what were, at the time, the active ingredients of 'party pills' in New Zealand. Since then, submissions of tablets and powders to the Institute of Environmental Science and Research (ESR) Limited have included ingredients not previously seen among drug seizures in New Zealand. These new components, confirmed by the synthesis of standards, included some beta-ketone (βk) analogues of 3,4-methylenedioxyamphetamine (MDA). Though not yet seen in tablet or powder seizures, the synthesis and the analytical data for βk-DMBDB ((beta-ketone)-N,N-dimethyl-1-(1,3-benzodioxol-5-yl)-2-butanamine) are reported here for the first time.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.forsciint.2011.03.005DOI Listing

Publication Analysis

Top Keywords

"party pill"
4
pill" components
4
zealand
4
components zealand
4
zealand synthesis
4
synthesis analysis
4
analysis β-ketone
4
β-ketone analogues
4
analogues 34-methylenedioxymethamphetamine
4
34-methylenedioxymethamphetamine mdma
4

Similar Publications

The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice.

Eur J Pharmacol

September 2024

Department of Pharmacology and Toxicology, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand. Electronic address:

Article Synopsis
  • The study explores the dangers of the synthetic cannabinoid AMB-FUBINACA, which is linked to severe health risks and fatalities, especially when combined with other drugs like pFPP and risperidone.
  • Experiments on mice showed that AMB-FUB leads to harmful effects like hypothermia and convulsions, with the combination of AMB-FUB and pFPP worsening these effects; however, risperidone mitigated the convulsions in female mice.
  • Understanding the mechanisms behind AMB-FUB toxicity is crucial for developing effective treatments for overdoses and protecting at-risk groups who abuse synthetic cannabinoids.
View Article and Find Full Text PDF

We present an exploration of the chemiluminescence from reactions of benzylpiperazines and phenylpiperazines with tris(2,2'-bipyridine)ruthenium(III). The selectivity of the reagent towards these compounds was found to be highly dependent upon the pH of the solution, and the relative emission intensity was strongly influenced by electron donating or withdrawing substituents on the phenyl or benzyl ring. In spite of previous investigations showing poor responses for aromatic-substituted amines (compared to their aliphatic amine counterparts), intense emissions were observed with phenylpiperazines under acidic conditions, particularly those with halogen or trifluoromethyl substituents on the aromatic ring.

View Article and Find Full Text PDF

Aim: To determine the content and release kinetics of 1-benzylpiperazine (BZP) and 1-(3-trifluoromethyl-phenyl)piperazine (TFMPP) from "party pill" formulations. From these data, the possible impact of pharmaceutical quality upon the safety of such illicit formulations may be inferred.

Methods: The amount of BZP and TFMPP in party pill formulations was determined using a validated HPLC method.

View Article and Find Full Text PDF

Estrogenic effects and their action mechanism of the major active components of party pill drugs.

Toxicol Lett

November 2012

School of Pharmacy, Sungkyunkwan University, 300 Cheoncheon dong, Jangan-gu, Suwon, Kyeonggi-do 440-746, South Korea.

Benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) are commonly used constituents of party pill drugs. They are reported to induce psychoactive effects such as euphoria and provide effects similar with other illicit drugs such as methylenedioxymethamphetamine (MDMA). A great deal of evidence has proven that party pills, as alternatives for MDMA, exert harmful effects on users.

View Article and Find Full Text PDF

The use of piperazine derivatives, colloquially named 'party pills', has been escalating in New Zealand and worldwide since their introduction in the 1990s. Benzylpiperazine (BZP) is often used alone, or can be combined with trifluoromethylphenylpiperazine (TFMPP). Taken together as an oral dose, they have been reported to produce effects similar to 3, 4-methylenedioxymethamphetamine (MDMA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!